Cargando…

Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers

BACKGROUND: Impaired myocardial blood flow (MBF) in the absence of epicardial coronary disease is a feature of hypertrophic cardiomyopathy (HCM). Although most evident in hypertrophied or scarred segments, reduced MBF can occur in apparently normal segments. We hypothesized that impaired MBF and myo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hughes, Rebecca K., Camaioni, Claudia, Augusto, João B., Knott, Kristopher, Quinn, Ellie, Captur, Gabriella, Seraphim, Andreas, Joy, George, Syrris, Petros, Elliott, Perry M., Mohiddin, Saidi, Kellman, Peter, Xue, Hui, Lopes, Luis R., Moon, James C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475659/ https://www.ncbi.nlm.nih.gov/pubmed/34310159 http://dx.doi.org/10.1161/JAHA.120.020227

Ejemplares similares

Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy
por: Camaioni, Claudia, et al.
Publicado: (2020)

Apical Hypertrophic Cardiomyopathy: The Variant Less Known
por: Hughes, Rebecca K., et al.
Publicado: (2020)

Apical Ischemia Is a Universal Feature of Apical Hypertrophic Cardiomyopathy
por: Hughes, Rebecca K., et al.
Publicado: (2023)

Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers
por: Lorenzini, Massimiliano, et al.
Publicado: (2020)

Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and Overt Hypertrophic Cardiomyopathy
por: Joy, George, et al.
Publicado: (2023)

Familial cardiomyopathy caused by a novel heterozygous mutation in the gene LMNA (c.1434dupG): a cardiac MRI-augmented segregation study
por: ALFARIH, MASHAEL, et al.
Publicado: (2019)

Abnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy
por: Reant, Patricia, et al.
Publicado: (2015)

It's not just the mitral valve - abnormal motion of the whole aorto-mitral apparatus occurs in both overt and subclinical hypertrophic cardiomyopathy
por: Obianyo, Chinwe, et al.
Publicado: (2016)

Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing
por: Lopes, Luis R, et al.
Publicado: (2013)

Almanac 2011: Cardiomyopathies. the National Society Journals Present Selected Research That Has Driven Recent Advances in Clinical Cardiology
por: M. Elliott, Perry, et al.
Publicado: (2011)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

The embryological basis of subclinical hypertrophic cardiomyopathy
por: Captur, Gabriella, et al.
Publicado: (2016)

A Novel Myosin Essential Light Chain Mutation Causes Hypertrophic Cardiomyopathy with Late Onset and Low Expressivity
por: Andersen, Paal Skytt, et al.
Publicado: (2012)

Subclinical Hypertrophic Cardiomyopathy in Elite Athletes: Knowledge Gaps Persist
por: Chan, Fiona, et al.
Publicado: (2022)

Novel genotype–phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy
por: Lopes, Luis R, et al.
Publicado: (2015)

Quantitative myocardial perfusion in coronary artery disease: A perfusion mapping study
por: Knott, Kristopher D., et al.
Publicado: (2019)

Pulmonary blood volume index as a quantitative biomarker of haemodynamic congestion in hypertrophic cardiomyopathy
por: Ricci, Fabrizio, et al.
Publicado: (2019)

CMR detects abnormal septal convexity into the left ventricle in preclinical hypertrophic cardiomyopathy
por: Reant, Patricia, et al.
Publicado: (2015)

Therapeutic benefits of distal ventricular pacing in mid-cavity obstructive hypertrophic cardiomyopathy
por: Malcolmson, James W., et al.
Publicado: (2022)

Myoarchitectural disarray of hypertrophic cardiomyopathy begins pre‐birth
por: Garcia‐Canadilla, Patricia, et al.
Publicado: (2019)

The clinical and CMR Characteristics of Hypertrophic Cardiomyopathy with Restrictive Phenotype
por: Lu, Minjie, et al.
Publicado: (2016)

Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives: Evidence for a Change in Paradigm
por: Norrish, Gabrielle, et al.
Publicado: (2019)

Genotype positive hypertrophic cardiomyopathy is associated with myocardial perfusion abnormalities
por: Keenan, Niall G, et al.
Publicado: (2014)

Myocardial contrast echocardiography assessment of perfusion abnormalities in hypertrophic cardiomyopathy
por: Roldan, Paola, et al.
Publicado: (2022)

Prognostic Value of Pulmonary Transit Time and Pulmonary Blood Volume Estimation Using Myocardial Perfusion CMR
por: Seraphim, Andreas, et al.
Publicado: (2021)

The Prognostic Significance of Quantitative Myocardial Perfusion: An Artificial Intelligence–Based Approach Using Perfusion Mapping
por: Knott, Kristopher D., et al.
Publicado: (2020)

Use of quantitative cardiovascular magnetic resonance myocardial perfusion mapping for characterization of ischemia in patients with left internal mammary coronary artery bypass grafts
por: Seraphim, Andreas, et al.
Publicado: (2021)

Heart Rate Recovery in Patients With Hypertrophic Cardiomyopathy
por: Patel, Vimal, et al.
Publicado: (2014)

Prevalence of Hypertrophic Cardiomyopathy in the UK Biobank Population
por: Lopes, Luis R., et al.
Publicado: (2021)

Stress perfusion CMR in hypertrophic cardiomyopathy: comparison with late gadolinium enhancement
por: Villa, Adriana, et al.
Publicado: (2014)

Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy
por: Salazar-Mendiguchía, Joel, et al.
Publicado: (2020)

Extracellular volume fraction is associated with B-type natriuretic peptide in hypertrophic cardiomyopathy
por: Wong, Timothy C, et al.
Publicado: (2014)

Wave intensity analysis and assessment of myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy
por: Raphael, Claire E, et al.
Publicado: (2015)

Lamin mutation location predicts cardiac phenotype severity: combined analysis of the published literature
por: Captur, Gabriella, et al.
Publicado: (2018)

Impact of catheter ablation on atrial fibrillation burden and symptoms in patients with hypertrophic cardiomyopathy
por: Ahluwalia, N, et al.
Publicado: (2023)

Myocardial Structural Alteration and Systolic Dysfunction in Preclinical Hypertrophic Cardiomyopathy Mutation Carriers
por: Yiu, Kai Hang, et al.
Publicado: (2012)

Preclinical alterations in cardiac energetics amongst sarcomere mutation carriers in hypertrophic cardiomyopathy
por: Lloyd, Rachael, et al.
Publicado: (2015)

Different Phenotypes in Monozygotic Twins, Carriers of the Same Pathogenic Variant for Hypertrophic Cardiomyopathy
por: Rodríguez Junquera, Manuel, et al.
Publicado: (2022)

Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy
por: Braunwald, Eugene, et al.
Publicado: (2023)

In vivo diffusion-weighted MRI detection of myocardial fibrosis in hypertrophic cardiomyopathy patients
por: Nguyen, Christopher T, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7ieene6luk4msnge8lnigs1cto